10.25384/SAGE.7893434.v1
Claire Liefferinckx
Claire
Liefferinckx
Bram Verstockt
Bram
Verstockt
Ann Gils
Ann
Gils
Sophie Tops
Sophie
Tops
Wouter Van Moerkercke
Wouter
Van Moerkercke
Severine Vermeire
Severine
Vermeire
Denis Franchimont
Denis
Franchimont
Supplemental material for Impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseases
SAGE Journals
2019
Induction
inflammatory bowel disease
infliximab
pharmacokinetics
trough level
vedolizumab
wash-out
2019-03-24 12:00:00
Journal contribution
https://sage.figshare.com/articles/journal_contribution/Supplemental_material_for_Impact_of_first-line_infliximab_on_the_pharmacokinetics_of_second-line_vedolizumab_in_inflammatory_bowel_diseases/7893434
<p>Supplemental Material for Impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseases by Claire Liefferinckx, Bram Verstockt, Ann Gils, Sophie Tops, Wouter Van Moerkercke, Severine Vermeire and Denis Franchimont in United European Gastroenterology Journal</p>